As of 2024-10-09, the Fair Value of Agios Pharmaceuticals Inc (AGIO) is -160.37 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 40.50 USD, the upside of Agios Pharmaceuticals Inc is -495.96%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -411.47 | -327.37 | 1,604.72 | -231.80 | -352.09 | 56.40 |
| YoY growth | -18.91% | 20.44% | 590.19% | -114.44% | -51.89% | 85.07% |
| Market Cap (mil) | 2,304.05 |
| P/E | |
| Forward P/E |
| EPS | -6.41 |
| Avg earnings growth rate | 85.07% |
| TTM earnings | -364.93 |